The new device, designed to perform mitral valve repair in patients with functional MR, was co-invented by cardiologist Samir Kapadia, MD, and surgeon Jose Navia, MD.
“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.